Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yin Qiao San
- Development stage
- Phase 4
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Oral
01
Overview
Yin Qiao San is a classical Traditional Chinese Medicine (TCM) herbal formula first recorded in 1798 AD. It is primarily used as an early intervention for upper respiratory tract infections presenting with wind-heat symptoms such as fever, sore throat, headache, nasal congestion, slight chills, and body aches. The formula’s principal ingredients are honeysuckle flower (Jin Yin Hua) and forsythia fruit (Lian Qiao), supported by other herbs including burdock fruit (Niu Bang Zi), platycodon root (Jie Geng), peppermint leaf (Bo He), fermented soybean (Dan Dou Chi), schizonepeta herb (Jing Jie), lophatherum leaf (Dan Zhu Ye), licorice root (Gan Cao), and phragmites rhizome (Lu Gen). Yin Qiao San works by dispersing wind-heat from the exterior of the body while clearing internal heat and resolving toxicity. Modern research attributes anti-inflammatory, antibacterial, antiviral effects to its components. It is widely used in China and internationally as a natural remedy for colds/flu-like illnesses[1][4][5][7].
- Brand names
- Yin Qiao SanHoneysuckle & Forsythia FormulaHoneysuckle and Forsythia PowderLonicera and Forsythia combinationForsythia Lonicera Powder
- Other names
- 银翘散Yín Qiào Sàn
02
Targets
ACE2 (Angiotensin-converting enzyme 2)MAPK3 (Mitogen-activated protein kinase 1)Mpro (3C-like proteinase of SARS-CoV-2)TNFRSF1A (Tumor necrosis factor receptor superfamily member 1A)
Beyond the preview
Go deeper on Yin Qiao San.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yin Qiao San.